论文部分内容阅读
非霍奇余淋巴瘤（NHL）、多发性骨髓瘤（MM）治疗后产牛多药耐药（MDR）导致的难治性病例使临床医生束手无策。紫杉醇（Paclitaxel）作为新的一种抗有丝分裂药物在耐药性卵巢癌的治疗中显示出良好的疗效。rJ前国内尚无用于难治性NHL，MM的报道。我院从1997年4月开始使用安素泰
The treatment of non-Hodgkin lymphoma (NHL) and multiple myeloma (MM)-producing refractory cases caused by multidrug resistance (MDR) in cattle has prevented clinicians from doing so. Paclitaxel (Paclitaxel) as a new anti-mitotic drug has shown good efficacy in the treatment of drug resistant ovarian cancer. There is no report on refractory NHL and MM before rJ. Our hospital began using Astaxe in April 1997